The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis

Xiaojia Sun, Motozumi Minohara, Hitoshi Kikuchi, Takaaki Ishizu, Masahito Tanaka, Hua Piao, Manabu Osoegawa, Yasumasa Ohyagi, Hiroaki Shimokawa, Jun ichi Kira

研究成果: Contribution to journalArticle査読

64 被引用数 (Scopus)

抄録

We studied the role of fasudil, a selective Rho-kinase inhibitor, in experimental autoimmune encephalomyelitis (EAE). Both parenteral and oral administration of fasudil prevented the development of EAE induced by proteolipid protein (PLP) p139-151 in SJL/J mice. Specific proliferation of lymphocytes to PLP was significantly reduced, together with a downregulation of interleukin (IL)-17 and a marked decrease of the IFN-γ/IL-4 ratio. Immunohistochemical examination also disclosed a marked decrease of inflammatory cell infiltration, and attenuated demyelination and acute axonal transaction. These results may provide a rationale of selective blockade of Rho-kinase by oral use of fasudil as a new therapy for multiple sclerosis.

本文言語英語
ページ(範囲)126-134
ページ数9
ジャーナルJournal of Neuroimmunology
180
1-2
DOI
出版ステータス出版済み - 11 2006

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

フィンガープリント 「The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル